Michael Ellison, PhD

Publications

• Ellison MA, Thurman GW, Ambruso DR. Phox activity of differentiated PLB-985 cells is enhanced, in an agonist specific manner, by the PLA2 activity of Prdx6-PLA2. Eur J Immunol. 2012 Jun;42(6):1609-17. PubMed PMID: 22678913
• Ellison MA, Ambruso DR, Silliman CC. Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor. Curr Pharm Des. 2012;18(22):3255-9. PubMed PMID: 22621271
• Ambruso DR, Ellison MA, Thurman GW, Leto TL. Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activity. Biochim Biophys Acta. 2012 Feb;1823(2):306-15. PubMed PMID: 22178385
• Dzieciatkowska M, Silliman CC, Moore EE, Kelher MR, Banerjee A, Land KJ, Ellison M, Ambruso DR, Hansen K. Proteomic Analysis of the Supernatent of Red Blood Cell Units: The Effects of Storage and Leukoreduction.
• Michael A. Ellison, Daniel R. Ambruso, and Gail Thurman Peroxiredoxin 6 Enhances Phagocyte NADPH Oxidase (phox) Activity in Response to Agonists Acting Via Cell Surface Receptors and Intracellular Signaling Pathways. Blood (ASH Annual Meeting Abstracts), Nov 2012; 120: 2139.